Why the study?
Does a disease-guided approach using CAC or carotid plaque improve statin allocation in elderly people?
Does a disease-guided approach using CAC or carotid plaque improve statin allocation in elderly people?
A disease-guided approach using CAC or carotid plaque to withhold statins could spare many elderly individuals from unnecessary medication.
Should not yet change statin decisions in elderly patients; leaves open whether CAC- or plaque-guided allocation improves outcomes.
Withholding statins in individuals without CAC or carotid plaque could spare a significant proportion of elderly people from taking a pill that would benefit only a few. This individualized disease-guided approach is simple and easy to implement in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Mortensen et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: